Amedica Files For IPO

Salt Lake City, Utah-based Amedica, a company developing silicon nitride ceramic technologies used for spine and joint implants, said in a filing with the SEC Tuesday evening that it is looking to raise up to $75.7M in an initial public offering on the Nasdaq Global Market. The firm said in its filing that it has applied for listing under the symbol AMCA. The IPO is being underwritten by Morgan Stanley, Jefferies & Company, and CIBC World Markets. Institutional stockholders in the firm include Vestal Venture Capital.